Page 2 - Immune Cell News Today

While working to map every cell in the human body, scientists uncovered an elusive type of immune cell that first emerges in the womb. The existence of such cells in humans has been hotly debated — until now. These mysterious

This study demonstrated that DNTTIP1/2 had diagnostic and prognostic value in low-grade glioma patients.

IIT Indore has summarized the study to understand post COVID-19 infection in terms of adjunct therapies and steroidal after-effects.

Development of lungs immune cells after birth has been revealed by a study that may further help for the continued development of important lung disease treatments.

LifeBank Chain (LBC) focuses on research and development in the field of genetics and cell science, with the purposes of furthering human longevity and...

A new study can tell allegedly how many SARS-CoV-2 are asymptomatic. However, the nature of the asymptomatic infection is not fully understood or how the virus progresses.

(Photo : Pete Linforth /Pixabay ) A new kind of virulent COVID-19 type does happen as it evolves. Despite the spate of inoculations to prove everyone against the virus, nature will come up with a standard countermeasure, but it does not mean all are deadly. Thus far, efforts to contain the pandemic by disseminating antibodies in this way appear to work, yet recent research suggests that even now, it may be a wrong time to relax our vigilance. In a study done by the Institute of Science and Tec...

Jul 9th, 2021 The following highlights summarize research articles that are published in the July 2010 issue of the American Journal of Pathology. Immune Cells and Atherosclerosis Dr. Einar Eriksson and colleagues at the Karolinska Hosptial, Stockholm, Sweden demonstrate that neutrophils may contribute to atherosclerosis. Their report can be found in the July 2010 issue of The American Journal of Pathology. Atherosclerosis is a hardening of the arteries due to the build-up of plaques made up of...

Share: MILAN, Italy and NEW YORK, May 10, 2021 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biotechnology company pioneering the development of a hematopoietic stem cell gene therapy for cancer (Temferon™), announced it will be presenting at several upcoming scientific congresses in May and June. Details of the presentations are as follows: American Society of Cell and Gene Therapy (ASGCT) 24 th Annual Meeting, May 11-14, virtual Title: Changes in the Tumor Microenvironment in Pa...

New study decodes why Covid-19 lasts longer, causes more damage than typical pneumonia SECTIONS Last Updated: Jan 12, 2021, 04:38 PM IST Share Synopsis Instead of rapidly infecting large regions of the lung, the coronavirus sets up shop in multiple small areas and hijacks the hosts immune cells. iStock According to the research, the coronavirus infection leaves damage in its wake as it slowly moves across the lung and continuously fuels the fever, low blood pressure, and damage to the kidneys, ...